Clinical Observation Of Irritable Bowel Syndrome Diarrheal Type Treated Of Live Stagnation And Spleen Deficiency Syndrome By Qihuang Suppository

Objective:To observe the clinical efficacy and clinical safety of qi huang suppository in the treatment of irritable bowel syndrome diarrhea type(liver-stagnation and spleen-deficiency type),and to provide new treatment ideas and drug options for the clinical treatment of gastrointestinal diseases in the elderly,and to summarize clinical experience and enrich medical evidence.Methods:In this study,72 patients meeting the diagnostic criteria were randomly divided into experimental group and control group.The experimental group was given the anal insertion of astragalus suppository,and the control group was given the live bacillus coagulans tablets combined with montmorillonite powder.The score changes of TCM syndrome score quantification table,ibs-sss scale and HAMA scale were analyzed.Meanwhile,the safety indicators of liver and kidney function and three major routines were monitored.Results:1.A total of 72 patients were included in this study,5 of whom were lost in the test group,31 of whom were effective,with a completion ratio of 86.11%.In the control group,4cases were lost,32 cases were effective,and the completion ratio was 88.88%.The total completion ratio is 87.5%.The comparison of the two groups in the general situation analysis(P > 0.05)was comparable.The experimental group and the control group were better than the control group in terms of improving the scores of stools,abdominal pain,irritability,pleural fullness,and nervation symptoms(P<0.05).2.Compared with the score of ibs-sss scale,the treatment group of the experimental group had better efficacy in improving the symptoms of defecation habit,abdominal pain,abdominal distension and quality of life than the control group(P < 0.05).3.Analysis of the integral quantification table of TCM symptoms: before and after treatment,the two groups had various indicators such as stool characteristics,abdominal pain,impatience,irritability,pleural fullness,and retention.The experimental group was superior to the control group in improving the efficacy of TCM symptoms and scoring(P< 0.05).There was no significant difference between the two groups in improving Chinese medicine symptoms of burnout before and after treatment.(P > 0.05).4.HAMA score improved efficacy comparison: the experimental group was superior to the control group in the efficacy and score of improving anxiety symptoms(P < 0.05).5.Analysis of the clinical observation table of safety indicators: there was no difference between the two groups in the clinical observation scale(blood routine,urine routine,stool routine,liver and kidney function)before and after the test and treatment(P > 0.05).Conclusion:Studies have shown that astragalus suppository has a good clinical effect on patients with diarrhea type of irritable bowel syndrome(liver-qi and spleen-spleen deficiency syndrome),with no adverse reactions,indicating that astragalus suppository is safe.Therefore,astragalus root suppository is worthy of clinical application.